Randomized trial identifies glycaemic patterns and associations in haemodialysis patients with diabetes, suggesting CGM's broader application.
CGM identifies dialysis-specific glycaemic patterns and clinically relevant associations with IDWG and intradialytic hypoglycaemia that extend beyond HbA1c. These findings support broader evaluation of CGM in haemodialysis populations with diabetes to inform future CGM-guided strategies.
No takes yet. Share an insight, caveat, or question.
Liarakos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: